- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cansino Biologics Inc. (6185)
Cansino Biologics Inc. stock price live, this page displays HK 6185 stock exchange data. View the 6185 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cansino Biologics Inc. real time stock price chart below.
What Is the Cansino Biologics Inc. Stock Price Today?
The Cansino Biologics Inc. stock price today is 50.60.
What Is the Stock Symbol for Cansino Biologics Inc.?
The stock symbol for Cansino Biologics Inc. is ""6185.""
What Stock Exchange Does Cansino Biologics Inc. Trade On?
Cansino Biologics Inc. is listed and trades on the Hong Kong stock exchange.
Is Cansino Biologics Inc. a Good Stock to Buy?
Determining whether Cansino Biologics Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6185 quote. (ISIN: CNE100003F01)
What Is the Cansino Biologics Inc. Stock Price Today?
The Cansino Biologics Inc. stock price today is 50.60.
What Is the Stock Symbol for Cansino Biologics Inc.?
The stock symbol for Cansino Biologics Inc. is ""6185.""
What Stock Exchange Does Cansino Biologics Inc. Trade On?
Cansino Biologics Inc. is listed and trades on the Hong Kong stock exchange.
Is Cansino Biologics Inc. a Good Stock to Buy?
Determining whether Cansino Biologics Inc.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 6185 quote. (ISIN: CNE100003F01)
50.60
+1.14(+2.30%)
Closed·
Fair Value
An estimate of a Cansino Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48.60
50.80
52 wk Range
16.34
55.70
6185 Scorecard
Full Analysis
Net income is expected to grow this year
6185 is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Cansino Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
48.6050.80
52 wk Range
16.3455.70
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
6185 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Cansino Biologics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
43.11
Downside
-14.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Significant return over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Cansino Biologics Inc. Company Profile
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N. meningitides. It develops DTcP vaccine for infants and DTcP Booster vaccine, which are in Phase I clinical trial for addressing the weaker protection preventing pertussis after primary vaccination. In addition, it develops Tdcp Adolescent and Adult vaccine for treating pertussis; PBPV, a serotype-independent protein-based pneumococcal vaccine that is in Phase I clinical trial; PCV13i, a pneumococcal conjugate vaccine, which is in Phase I clinical trial; and TB Booster for the BCG-vaccinated population which is in Phase I clinical trial. Further, it is developing various preclinical stage products, including DTcP-Hib Combo vaccine; CS-2023 to treat meningitis; CS-2028 for treating multivalent conjugate vaccine; CS-2032 for hingles; CS-2036 to treat polio; CS-2047 for treating tetanus; and CS-2201 DTcP for combination vaccine. The company was incorporated in 2009 and is headquartered in Tianjin, the People’s Republic of China.
Compare 6185 to Peers and Sector
Metrics to compare | 6185 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6185PeersSector | |
|---|---|---|---|---|
P/E Ratio | −72.0x | −16.3x | −0.5x | |
PEG Ratio | −0.85 | 0.30 | 0.00 | |
Price/Book | 3.2x | 6.3x | 2.6x | |
Price / LTM Sales | 18.2x | 23.8x | 3.3x | |
Upside (Analyst Target) | −15.0% | −0.6% | 43.3% | |
Fair Value Upside | Unlock | −14.8% | 6.9% | Unlock |
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 43.11
(-14.81% Downside)
Earnings
Latest Release
Apr 29, 2025
EPS / Forecast
-0.05 / --
Revenue / Forecast
137.16M / --
People Also Watch
FAQ
What Stock Exchange Does Cansino Biologics Trade On?
Cansino Biologics is listed and trades on the Hong Kong Stock Exchange stock exchange.
What Is the Stock Symbol for Cansino Biologics?
The stock symbol for Cansino Biologics is "6185."
What Is the Cansino Biologics Market Cap?
As of today, Cansino Biologics market cap is 17.35B.
What Is Cansino Biologics's Earnings Per Share (TTM)?
The Cansino Biologics EPS (TTM) is -0.90.
When Is the Next Cansino Biologics Earnings Date?
Cansino Biologics will release its next earnings report on 23 Oct 2025.
From a Technical Analysis Perspective, Is 6185 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Cansino Biologics Stock Split?
Cansino Biologics has split 0 times.
How Many Employees Does Cansino Biologics Have?
Cansino Biologics has 1105 employees.
What is the current trading status of Cansino Biologics (6185)?
As of 11 Aug 2025, Cansino Biologics (6185) is trading at a price of 50.60, with a previous close of 50.60. The stock has fluctuated within a day range of 48.60 to 50.80, while its 52-week range spans from 16.34 to 55.70.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.